Myriad Genetics, Inc.
MYGN US62855J1043
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 39% | -48% | 25% | -28% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Diaz Paul J CEO |
22.93 USD |
15,000 Sold |
343,950 USD |
11/10/2024 | 11/10/2024 |
| Muzzey Dale CSO |
26.17 USD |
2,100 Sold |
54,961 USD |
11/09/2024 | 11/09/2024 |
| Diaz Paul J CEO |
26.72 USD |
15,000 Sold |
400,800 USD |
11/09/2024 | 11/09/2024 |
| Dreismann Heinrich |
27.05 USD |
10,000 Sold |
270,520 USD |
09/09/2024 | 09/09/2024 |
| Reitan Colleen F |
27.95 USD |
46,012 Sold |
1,285,851 USD |
03/09/2024 | 03/09/2024 |
| Ancona Margaret VP |
27.82 USD |
11,538 Sold |
320,987 USD |
21/08/2024 | 21/08/2024 |
| Kumar Rashmi |
28.01 USD |
7,500 Sold |
210,075 USD |
19/08/2024 | 19/08/2024 |
| Spiegelman Daniel K |
22.05 USD |
3,788 Sold |
83,525 USD |
03/06/2024 | 04/06/2024 |
| Spiegelman Daniel K |
22.04 USD |
3,788 Sold |
83,488 USD |
03/06/2024 | 03/06/2024 |
| Diaz Paul J CEO |
25.07 USD |
75,000 Sold |
1,880,415 USD |
13/05/2024 | 15/05/2024 |